Product NDC: | 16729-064 |
Proprietary Name: | Levetiracetam |
Non Proprietary Name: | levetiracetam |
Active Ingredient(s): | 250 mg/1 & nbsp; levetiracetam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16729-064 |
Labeler Name: | Accord Healthcare Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090843 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110314 |
Package NDC: | 16729-064-29 |
Package Description: | 120 TABLET, FILM COATED in 1 BOTTLE (16729-064-29) |
NDC Code | 16729-064-29 |
Proprietary Name | Levetiracetam |
Package Description | 120 TABLET, FILM COATED in 1 BOTTLE (16729-064-29) |
Product NDC | 16729-064 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levetiracetam |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110314 |
Marketing Category Name | ANDA |
Labeler Name | Accord Healthcare Inc. |
Substance Name | LEVETIRACETAM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |